Sign In
Buy INBP
$0.180
-0.0089 (-4.71%)
At Close: Jun 22, 2026
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
04:30pm, Friday, 08'th May 2026
HILLSIDE, NJ / ACCESS Newswire / May 8, 2026 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2026. Revenue for the q
Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025
04:30pm, Wednesday, 11'th Feb 2026
HILLSIDE, NJ / ACCESS Newswire / February 11, 2026 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2025. Revenue fo
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
04:00am, Tuesday, 02'nd Dec 2025
LAUPHEIM, Germany and MARTINSRIED, Germany and MUNICH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharma
Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025
03:50pm, Monday, 10'th Nov 2025
HILLSIDE, NJ / ACCESS Newswire / November 10, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2025. Revenue f
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025
03:40pm, Tuesday, 23'rd Sep 2025
HILLSIDE, NJ / ACCESS Newswire / September 23, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 202
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025
03:30pm, Wednesday, 14'th May 2025
HILLSIDE, NJ / ACCESS Newswire / May 14, 2025 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2025. Revenue for the
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024
03:55pm, Thursday, 13'th Feb 2025
HILLSIDE, NJ / ACCESS Newswire / February 13, 2025 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2024. Revenue fo
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024
05:33pm, Wednesday, 13'th Nov 2024
HILLSIDE, NJ / ACCESSWIRE / November 13, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2024. Revenue for th
Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
05:40pm, Friday, 20'th Sep 2024
HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2024. Re
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
04:30pm, Friday, 10'th May 2024
HILLSIDE, NJ / ACCESSWIRE / May 10, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2024. Revenue for each of the
Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023
04:25pm, Monday, 12'th Feb 2024
HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for the
Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023
02:15pm, Thursday, 09'th Nov 2023
HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023. Revenue for the
Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023
05:15pm, Friday, 15'th Sep 2023
HILLSIDE, NJ / ACCESSWIRE / September 15, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2023. Re
Integrated BioPharma GAAP EPS of $0.03, revenue of $14.6M
07:57am, Friday, 11'th Feb 2022 Seeking Alpha
Integrated BioPharma press release (INBP): FQ2 GAAP EPS of $0.03.Revenue of $14.6M (+2.4% Y/Y).
OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX
07:00am, Friday, 22'nd Jan 2021
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Integrated BioPharma, Inc. (OTCQX: IN
